These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias. Berdel WE; Schick HD; Fink U; Reichert A; Ulm K; Rastetter J Cancer Res; 1985 Mar; 45(3):1206-13. PubMed ID: 3971369 [TBL] [Abstract][Full Text] [Related]
7. Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. Engebraaten O; Bjerkvig R; Berens ME Cancer Res; 1991 Mar; 51(6):1713-9. PubMed ID: 1998962 [TBL] [Abstract][Full Text] [Related]
8. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance. Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors. Berdel WE; Fink U; Egger B; Reichert A; Munder PG; Rastetter J J Natl Cancer Inst; 1981 May; 66(5):813-7. PubMed ID: 6939927 [TBL] [Abstract][Full Text] [Related]
10. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Lu X; Arthur G Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895 [TBL] [Abstract][Full Text] [Related]
11. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids. Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806 [TBL] [Abstract][Full Text] [Related]
12. Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine. Van Der Luit AH; Budde M; Verheij M; Van Blitterswijk WJ Biochem J; 2003 Sep; 374(Pt 3):747-53. PubMed ID: 12837133 [TBL] [Abstract][Full Text] [Related]
13. Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid. Andreesen R; Munder PG J Natl Cancer Inst; 1983 Apr; 70(4):623-7. PubMed ID: 6300501 [TBL] [Abstract][Full Text] [Related]
15. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Modolell M; Andreesen R; Pahlke W; Brugger U; Munder PG Cancer Res; 1979 Nov; 39(11):4681-6. PubMed ID: 498095 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro. Jendrossek V; Hammersen K; Erdlenbruch B; Kugler W; Krügener R; Eibl H; Lakomek M Cancer Chemother Pharmacol; 2002 Jul; 50(1):71-9. PubMed ID: 12111115 [TBL] [Abstract][Full Text] [Related]
17. Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues. Herrmann DB J Natl Cancer Inst; 1985 Sep; 75(3):423-30. PubMed ID: 3861897 [TBL] [Abstract][Full Text] [Related]
18. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells. Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197 [TBL] [Abstract][Full Text] [Related]
19. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines. Vogler WR; Whigham E; Bennett WD; Olson AC Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326 [TBL] [Abstract][Full Text] [Related]
20. Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368). Andreesen R; Modolell M; Oepke GH; Munder PG Exp Hematol; 1983 Jul; 11(6):564-70. PubMed ID: 6617791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]